Navigation Links
BioMarin Announces IND for BMN-111 for Achondroplasia is Active
Date:1/3/2012

NOVATO, Calif., Jan. 3, 2012 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the Investigational New Drug (IND) application for BMN-111, an analog of C-type Natriuretic Peptide (CNP), for achondroplasia is active.  The company expects to initiate the Phase 1 trial in the first quarter of 2012.

"BMN-111 has demonstrated benefits in moderately and severely affected animal models and has been shown to promote bone growth even in normal animals," stated Hank Fuchs, M.D., Chief Medical Officer of BioMarin.  "BMN-111 will mark our seventh program in the clinic, the most ever in the history of the company.  We look forward to many potentially value-creating clinical milestones in the coming year."

The primary objective of the Phase 1 trial is to assess the safety and tolerability of single and multiple doses of BMN-111 in normal adult healthy volunteers up to the maximum tolerated dose.  The company expects to start the Phase 2 study in pediatric subjects in the fourth quarter of 2012 or the first quarter of 2013.

About AchondroplasiaAchondroplasia is caused by an autosomal dominant activating mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, a negative regulator of bone growth. Eighty percent of cases are the result of a spontaneous mutation, and ninety-eight percent of those cases have a G380R mutation. Achondroplasia is the most common form of human dwarfism and is characterized by failure of normal conversion of cartilage into bone. Clinical manifestations of the disease include short stature, craniomedullary compression, apnea, bowed legs, frontal bossing and midface hypoplasia, permanent sway of the lower back, spinal stenosis, recurrent ear infections and obesity.

The rate of incidence of achondroplasia is one in 15,000 to one in 40,000 live births, with approximately 18,000 to
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility
2. Highlights from BioMarins Research & Development Day
3. BioMarin Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority
4. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
5. BioMarin Announces FDA Approval of Expanded Biologics Manufacturing Facility
6. BioMarin to Host a Research and Development Day on December 8th
7. BioMarin Announces Third Quarter 2011 Financial Results
8. BioMarin to Present at the UBS Global Life Sciences Conference
9. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
10. BioMarin to Present at the Baird Health Care Conference
11. BioMarin to Present at the Wedbush Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015 Sleep ... sleep therapy, and HGE Health Care Solutions, a ... announced today a comprehensive sleep management and cost ... (OSA). OSA is a chronic medical ... sleep and may increase a patient,s risk for ...
(Date:9/1/2015)... 1, 2015   Millstone Medical Outsourcing announced today ... in Olive Branch, MS. Now totaling ... facility has added the capacity required to meet the ... "This expansion gives us the opportunity to grow in parallel ... Millstone MS. "Two and a half years ago we were ...
(Date:9/1/2015)... Belgium , Sept. 1, 2015 VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... Executive Officer, Cameron Reynolds , is scheduled to attend ... is being held September 9-10, 2015 in Boston, ... on September 10. Wells Fargo Securities Research ...
Breaking Medicine Technology:Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2Millstone Medical Outsourcing Announces Olive Branch Expansion 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4
... in Ohio supported by the biopharmaceutical research sector would ... new taxes in the Medicare prescription drug program – ... to technical work, manufacturing to construction and other building ... sector supports a broad array of high-quality jobs. ...
... Sept. 27, 2011 Visiting Nurse Services of ... home health agencies, announces that it has entered ... advanced home telehealth technology to patients with chronic ... Experts in Telehealth(SM), is a world class developer, ...
Cached Medicine Technology:Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies 2Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies 3Visiting Nurse Services of Connecticut Selects Cardiocom® As Its New Telehealth Vendor 2
(Date:9/1/2015)... ... 01, 2015 , ... OncLive® today announced it ... & World Report, to provide breaking news and information about the hospital’s pioneering ... OncLive, which provides oncologists resources and information?they need to deliver the best care ...
(Date:9/1/2015)... ... 2015 , ... The Jerry Segal Classic to benefit the patients of Magee ... Club in Lafayette Hill, PA. Over the past 26 years, the Classic, organized by ... services designed to support patients and their families during their time at Magee Rehabilitation ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among ... Math) disciplines since its inception more than 35 years ago. A pilot program begun ... their teachers - and, not just those intent on pursuing careers in these fields. ...
(Date:9/1/2015)... Boston, MA (PRWEB) , ... September 01, 2015 ... ... solutions, today announced the release of version 5.2 of the FirstSpirit Content Management ... Content Cloud initiative. With the new version of FirstSpirit, companies will be well ...
(Date:9/1/2015)... ... 2015 , ... Zecurion, a leading developer of data loss prevention solutions, announced ... DLP developed specifically for Mac OS. , In June 2015, the company successfully completed ... security professionals had participated. The beta test done by the developer community enabled Zecurion ...
Breaking Medicine News(10 mins):Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:Zecurion Announces Endpoint Security for Mac 2
... the real thing may go further than first thought.Violent ... that makes people more likely to behave aggressively, says ... considered the effects of popular games such as Doom, ... killings, high-powered weaponry and street crime, indicates that avid ...
... Milwaukee Cardiologist, and Chief of the Specialty Hospital in ... dire need of a shot in the arm.//Specialty Hospitals ... prevailing healthcare systems, was nipped in the bud, owing ... opinion write-up in The Wall Street Journal, has expressed ...
... in every 100,000 in India suffer from stroke every year. ... Tamil Nadu for promoting awareness with regard to stroke in ... is very low.// ,The Indian Stroke Association ... a study report here which says around 20 million people ...
... between office work and private life, as they feel that ... during evenings and weekends //when they are with their family ... hours they find the mobile phones and pagers ringing from ... and work concentration. Most of the people feel that work ...
... and Industrial Research Organization (CSIRO) may increase the ... Nutritionist. //Dr. Stanton has asked the Australian Prime ... in recommending CSIRO diet as it contains high ... recommend the Australian Governments Australian Guide to Healthy ...
... Orr, a Canadian woman who has survived breast cancer twice, ... Herceptin. //Orr says that the life-saving and life-improving drug should ... deadly cancer have a chance of successfully fighting it. ... drug is federally funded in some provinces, while it is ...
Cached Medicine News:Health News:Violent computer games spur aggression: study 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: